Relevium_LOGO_200.jpg
Relevium Announces Settlement of the Outstanding Notes
30 juin 2021 11h19 HE | Relevium Technologies Inc
MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today it has reached an agreement to...
Relevium_LOGO_200.jpg
Relevium Announces Shareholder Townhall and Conference Call
15 juin 2021 10h11 HE | Relevium Technologies Inc
MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium_LOGO_200.jpg
Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders
10 juin 2021 08h11 HE | Relevium Technologies Inc
MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today the maturity of its...
Relevium_LOGO_200.jpg
Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation
20 mai 2021 02h00 HE | Relevium Technologies Inc
MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium_LOGO_200.jpg
Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves
05 mai 2021 09h47 HE | Relevium Technologies Inc
MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), whose primary mandate is to focus on...
Relevium_LOGO_200.jpg
Biocannabix Enters Into LOI With IAM Health GmbH
29 avr. 2021 09h12 HE | Relevium Technologies Inc
MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium_LOGO_200.jpg
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April
11 mars 2021 13h59 HE | Relevium Technologies Inc
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has...
Relevium_LOGO_200.jpg
Relevium Announces Investor Relations Conference Call
04 févr. 2021 16h48 HE | Relevium Technologies Inc
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium_LOGO_200.jpg
Relevium Reports Interim First Quarter Results for the Three-Month Period Ended September 30, 2020
25 janv. 2021 09h42 HE | Relevium Technologies Inc
MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the...
Relevium_LOGO_200.jpg
Relevium Reports Fiscal Year Ended June 30, 2020 Results
20 janv. 2021 07h11 HE | Relevium Technologies Inc
MONTREAL, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the...